By Sabela Ojea
Anew Health filed for an initial public offering with the Securities and Exchange Commission.
The medication-management and pharmacy-care provider on Friday said that it would issue 5 million ordinary shares at a price of $4 a share.
The company said it planned to list its shares on the Nasdaq Global Market under the symbol AVG.
The company expects to receive net proceeds from the offering of around $16.4 million, with around 30% of it planned for establishing a new treatment center in Hong Kong.
Anew Health reported revenue of $40.8 million for the fiscal year ended March 31, 2024, from $27.3 million for the same period a year earlier.
Write to Sabela Ojea at sabela.ojea@wsj.com
(END) Dow Jones Newswires
March 07, 2025 18:06 ET (23:06 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.